Contact
searchSearch
HMP Global
Login

Advertisement

ADVERTISEMENT

Videos

Christopher D'Avella, MD.
Videos
Using Provider Feedback to Improve Efficiency and Utilization of the Flatiron Assist EMR-Based Pathways Tool
08/14/2023

Featuring Christopher D'Avella, MD

Featuring Christopher D'Avella, MD ...
Christopher D’Avella, MD, talks about his institution’s use of the Flatiron Assist pathways program, and how the improvements made to the tool as a result of provider feedback increased the efficiency and utilization of the program.
Christopher D’Avella, MD, talks about his institution’s use of the Flatiron Assist pathways program, and how the improvements made to the tool as a result of provider feedback increased the efficiency and utilization of the program.
Christopher D’Avella, MD, talks...
08/14/2023
Journal of Clinical Pathways

Advertisement

Video preview thumbnail.
Videos
“Treating the Person: Integrating Support Services into Clinical Pathways” at the Clinical Pathways Congress with the Cancer Care Business Exchange
08/11/2023
Mary Cooley, PhD, Dana-Farber Cancer Institute, and David Lobach, MD, Elimu Informatics, provide an inside look into their CPC session “Treating the Person: Integrating Support Services into Clinical Pathways.”
Mary Cooley, PhD, Dana-Farber Cancer Institute, and David Lobach, MD, Elimu Informatics, provide an inside look into their CPC session “Treating the Person: Integrating Support Services into Clinical Pathways.”
Mary Cooley, PhD, Dana-Farber...
08/11/2023
Journal of Clinical Pathways
Scott Swain, PhD.
Videos
Comparing Diversity in Real-World Evidence With Diversity in Clinical Trial and SEER Data
08/10/2023
Scott Swain, PhD, discusses his study on comparison of diversity across real-world evidence with clinical trial and SEER data in patients with metastatic breast cancer.
Scott Swain, PhD, discusses his study on comparison of diversity across real-world evidence with clinical trial and SEER data in patients with metastatic breast cancer.
Scott Swain, PhD, discusses his...
08/10/2023
Journal of Clinical Pathways
Smita Agrawal, PhD.
Videos
Enhancing Line of Therapy Derivation Using Real-World Data From Electronic Health Records Via Integration of Medical Claims Data
08/08/2023

Featuring Smita Agrawal, PhD

Featuring Smita Agrawal, PhD
Smita Agrawal, PhD, executive director at ConcertAI, spoke about her study on deriving lines of therapy by integrating data from multiple data sources to improve accuracy.
Smita Agrawal, PhD, executive director at ConcertAI, spoke about her study on deriving lines of therapy by integrating data from multiple data sources to improve accuracy.
Smita Agrawal, PhD, executive...
08/08/2023
Journal of Clinical Pathways

Advertisement

Stop-Loss Insurance, Explained Thumbnail
Videos
Stop-Loss Insurance, Explained
08/07/2023

Featuring John Hennessy, MBA

Featuring John Hennessy, MBA
John Hennessy, MBA, Valuate Health Consultancy, gives an overview of stop-loss or provider-excess insurance: what it is, why more oncology providers are considering it, and the pros and cons.
John Hennessy, MBA, Valuate Health Consultancy, gives an overview of stop-loss or provider-excess insurance: what it is, why more oncology providers are considering it, and the pros and cons.
John Hennessy, MBA, Valuate...
08/07/2023
Cancer Care Business Exchange
Puneeth Indurlal, MD
Videos
Impact of Dose Rounding Bevacizumab and its Biosimilars on Total Cost of Care for OCM Participants
07/26/2023

Featuring Puneeth Indurlal, MD

Featuring Puneeth Indurlal, MD ...
Puneeth Indurlal, MD, discusses the impact of dose rounding that targets bevacizumab and its biosimilars on the total cost of care and drug waste expenditures for Oncology Care Model participants in the US Oncology Network.
Puneeth Indurlal, MD, discusses the impact of dose rounding that targets bevacizumab and its biosimilars on the total cost of care and drug waste expenditures for Oncology Care Model participants in the US Oncology Network.
Puneeth Indurlal, MD, discusses...
07/26/2023
Journal of Clinical Pathways
Health Care Sharing Plans, Explained Thumbnail
Videos
Health Care Sharing Programs, Explained
07/25/2023

Featuring John Hennessy, MBA

Featuring John Hennessy, MBA
John Hennessy, MBA, Valuate Health Consultancy, describes health care sharing programs and why 1.7 million Americans are choosing this option over traditional health insurance.
John Hennessy, MBA, Valuate Health Consultancy, describes health care sharing programs and why 1.7 million Americans are choosing this option over traditional health insurance.
John Hennessy, MBA, Valuate...
07/25/2023
Cancer Care Business Exchange

Advertisement

Monica Schmidt, PhD.
Videos
The Impact of Elsevier ClinicalPath Oncology Treatment Pathways on Survival and Cost of Care
07/24/2023

Featuring Monica Schmidt, PhD

Featuring Monica Schmidt, PhD
In an interview with the Journal of Clinical Pathways, Monica Schmidt, PhD, MPH, discusses her study on the impact of using Elsevier’s ClinicalPath oncology pathways on short-term survival and cost of care from the patient and health system...
In an interview with the Journal of Clinical Pathways, Monica Schmidt, PhD, MPH, discusses her study on the impact of using Elsevier’s ClinicalPath oncology pathways on short-term survival and cost of care from the patient and health system...
In an interview with the Journal...
07/24/2023
Journal of Clinical Pathways
Aaron P. Mitchell, MD, MPH
Videos
Study Examines the Association Between Oncologists’ Receipt of Pharmaceutical Industry Payments and Use of Nonrecommended/Low-Value Treatments
07/20/2023

Featuring Aaron P. Mitchell, MD

Featuring Aaron P. Mitchell, MD ...
Aaron P. Mitchell, MD, MPH, discusses his research on the association of pharmaceutical industry payments to oncologists and their increased use of nonrecommended and/or low-value treatment methods.
Aaron P. Mitchell, MD, MPH, discusses his research on the association of pharmaceutical industry payments to oncologists and their increased use of nonrecommended and/or low-value treatment methods.
Aaron P. Mitchell, MD, MPH,...
07/20/2023
Journal of Clinical Pathways
Manali Kamdar Headshot
Videos
Overview of Treatment Options for Patients With Primary Refractory/Early Relapse Diffuse Large B-Cell Lymphoma
07/19/2023

Featuring Manali Kamdar, MD

Featuring Manali Kamdar, MD
Manali Kamdar, MD, University of Colorado Cancer Center, discusses the latest therapeutic options available for patients with primary refractory/early relapse diffuse large B-cell lymphoma.
Manali Kamdar, MD, University of Colorado Cancer Center, discusses the latest therapeutic options available for patients with primary refractory/early relapse diffuse large B-cell lymphoma.
Manali Kamdar, MD, University of...
07/19/2023
Journal of Clinical Pathways

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

JCP May/June 2024 Issue

Current Issue

June 2024
Volume 10
Issue 3
Current Issue
Issue Archive

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Special Reports

JCP Special Report
Recommendations for Creating an Oncology Clinical Pathways Framework Tool Based on Payer, Provider, and Patient Priorities: Findings From the 2021 Care Pathways Working Group
05/20/2022
Winston Wong, PharmD
Gordon Kuntz
Robin T Zon, MD, FACP, FASCO
2021 Care Pathways Working Group
The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...
The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...
The Journal of Clinical Pathways...
05/20/2022
Journal of Clinical Pathways
Clinical Pathways Updates in Multiple Myeloma: New and Expected Treatments for Refractory and Resistant Multiple Myeloma
Special Report
Clinical Pathways Updates in Multiple Myeloma: New and Expected Treatments for Refractory and Resistant Multiple Myeloma
01/14/2021
01/14/2021
Journal of Clinical Pathways

Advertisement

Advertisement

Advertisement

Advertisement

Subscribe

Journal of Clinical Pathways Newsletter

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use